Hyderabad-based Indian Immunologicals Limited (IIL) an entirely owned subsidiary of the National Dairy Development Board, the main player in human and animal health, has launched VAXTAR 5, a pentavalent vaccine for children.
Developed with the company’s research and development expertise, it will be made at the IIL’s vaccine manufacturing facility in Hyderabad for the retail market and in addition, the national Universal Immunization Program implemented by the Union Ministry of Health and Family Welfare.
IIL is all set to make this vaccine in its state-of-the-art vaccine manufacturing facility in Hyderabad for the retail market and for the national “Universal Immunisation Programme” (UIP) implemented by Ministry of Health and Family Welfare (MoHFW), Government of India.
VAXTAR 5 (pentavalent vaccine with Pertussis, Diptheria, Tetanus, Hepatitis B, and HiB) is available in single dosage and multi-dose presentations. By using IIL’s R&D expertise the vaccine was developed indigenously and has been tested in multiple centers under prescribed government guidelines. IIL use its strength in manufacturing and quality assurance system to produce a highly viable and moderately priced vaccine.
Ministry of Health and Family Welfare, Government of India had introduced pentavalent vaccine some years ago and are scaling up utilization of pentavalent vaccine the country over. MoHFW acquires around 85 to 90 million doses of pentavalent antibody yearly.
Dr. K Anand Kumar, managing director, Indian Immunologicals Limited said, “For pentavalent vaccine in the recent tender floated by the Ministry of Health, IIL has risen as the most competitive bidder. There will be significant savings to the exchequer with IIL’s entry into the pentavalent market”.
IIL launched a few other human vaccines over the previous decade and has been effectively providing its Hepatitis B, DPT (Triple Antigen) and TT (Tetanus Toxoid) vaccines to the UIP program. IIL is also currently pursuing work on the hexavalent vaccine which includes inactivated polio antigen.